TCGA data analysis using gene expression data from 495 tumor and normal samples revealed almost 3.4-fold higher expression of GPR56 in tumor samples as compared to normal samples indicating an overall difference in expression of GPR56 in prostate cancer patients. Here, ADGRG1 is linked to Familial prostate cancer.